
BigHat Biosciences is a clinical-stage biotech that combines AI with an automated lab to design antibody therapeutics. Its Milliner platform generates the data used to train and improve its models.
Web appContact for pricing
Step 1: Read the platform page to see how Milliner works.
Step 2: Review the therapeutics pipeline.
Step 3: Use the partnering page to describe a protein design challenge.
Step 4: Contact the team at the address on the site.
It is BigHat's high-throughput data-generation engine that links computational design with automated experiments.
The company says it can design and evaluate thousands of antibodies each week.
Yes. BigHat engages with strategic partners on complex protein therapeutic design challenges.
BigHat is a clinical-stage biotech in San Mateo, California.
Charm TherapeuticsCharm Therapeutics applies AI to AI drug discovery company using protein-ligand structure modeling and molecular design for difficult therapeutic targets.
Relay Therapeutics DynamoRelay Therapeutics Dynamo applies AI to computational drug discovery platform modeling protein motion and molecular interactions to design targeted medicines.